Antimicrobial peptide GL13K is effective in reducing biofilms of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 10, 2013, Pages 4903-4910

  Hirt, Helmut ^a   Gorr, Sven Ulrik ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTIMICROBIAL PEPTIDE GL13K; COLISTIN; LEUCINE; LIPOPOLYSACCHARIDE; LYSINE; METALLOPROTEINASE; PAROTID SECRETORY PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; SECRETORY PROTEIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; CELL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; MICROBIAL COMMUNITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BIOFILMS; PEPTIDES; PSEUDOMONAS AERUGINOSA;

EID: 84884227799     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00311-13     Document Type: Article

References (35)

1. Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57:677-701.
2. Chen LF, Chopra T, Kaye KS. 2009. Pathogens resistant to antibacterial agents. Infect. Dis. Clin. North Am. 23:817-845, vii.
3. Yount NY, Yeaman MR. 2012. Emerging themes and therapeutic prospects for anti-infective peptides. Annu. Rev. Pharmacol. Toxicol. 52:337-360.
4. Jacob, L., Zasloff, M. 1994. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found. Symp. 186:197-223.
5. Yeung AT, Gellatly SL, Hancock RE. 2011. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol. Life Sci. 68: 2161-2176.
6. Bechinger B. 1999. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochim. Biophys. Acta 1462:157-183.
7. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. 2008. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol. 68:223-240.
8. Abdolhosseini M, Nandula SR, Song J, Hirt H, Gorr SU. 2012. Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity. Peptides 35:231-238.
9. Abdolhosseini M, Sotsky JB, Shelar AP, Joyce PB, Gorr SU. 2012. Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain. Mol. Cell. Biochem. 359:1-8.
10. Gorr SU, Abdolhosseini M, Shelar A, Sotsky J. 2011. Dual host-defence functions of SPLUNC2/PSP and synthetic peptides derived from the protein. Biochem. Soc. Trans. 39:1028-1032.
11. Bingle CD, Seal RL, Craven CJ. 2011. Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI foldcontaining superfamily. Biochem. Soc. Trans. 39:977-983.
12. Bingle CD, Gorr SU. 2004. Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int. J. Biochem. Cell Biol. 36:2144-2152.
13. Balhara V, Schmidt R, Gorr SU, Dewolf C. 2013. Membrane selectivity and biophysical studies of the antimicrobial peptide GL13K. Biochim. Biophys. Acta 1828:2193-2203.
14. Holloway BW. 1969. Genetics of Pseudomonas. Bacteriol. Rev. 33:419-443.
15. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603.
16. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. 1999. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37:1771-1776.
17. Palmer RJ, Jr, Kazmerzak K, Hansen MC, Kolenbrander PE. 2001. Mutualism versus independence: strategies of mixed-species oral biofilms in vitro using saliva as the sole nutrient source. Infect. Immun. 69:5794-5804.
18. Erlandsen SL, Kristich CJ, Dunny GM, Wells CL. 2004. High-resolution visualization of the microbial glycocalyx with low-voltage scanning electron microscopy: dependence on cationic dyes. J. Histochem. Cytochem. 52:1427-1435.
19. Werner E, Roe F, Bugnicourt A, Franklin MJ, Heydorn A, Molin S, Pitts B, Stewart PS. 2004. Stratified growth in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 70:6188-6196.
20. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS. 2004. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob. Agents Chemother. 48:2659-2664.
21. Schmidtchen A, Frick IM, Andersson E, Tapper H, Bjorck L. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46:157-168.
22. Herrmann G, Yang L, Wu H, Song Z, Wang H, Hoiby N, Ulrich M, Molin S, Riethmuller J, Doring G. 2010. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J. Infect. Dis. 202:1585-1592.
23. Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2:114-122.
24. Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW. 2003. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev. Anti Infect. Ther. 1:667-683.
25. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108.
26. Hawkey PM. 2008. The growing burden of antimicrobial resistance. J. Antimicrob. Chemother. 62(Suppl 1):i1-i9.
27. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1-12.
28. Peschel A, Sahl HG. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
29. Falagas ME, Kasiakou SK. 2006. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care 10:R27. doi:10.1186/cc3995.
30. Kapoor R, Wadman MW, Dohm MT, Czyzewski AM, Spormann AM, Barron AE. 2011. Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 55:3054-3057.
31. Hou S, Liu Z, Young AW, Mark SL, Kallenbach NR, Ren D. 2010. Effects of Trp-and Arg-containing antimicrobial-peptide structure on inhibition of Escherichia coli planktonic growth and biofilm formation. Appl. Environ. Microbiol. 76:1967-1974.
32. Hannig C, Follo M, Hellwig E, Al-Ahmad A. 2010. Visualization of adherent micro-organisms using different techniques. J. Med. Microbiol. 59:1-7.
33. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
34. Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB, Jr, Lehrer RI, Welsh MJ, Tack BF. 2000. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 68:2748-2755.
35. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.